Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemophilia Inhibitor PUP Study
NL-OMON39820Active, not recruiting
- Sponsor
- UTHealth Houston
- Start
- May 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of Factor VIII in hemophilia A, sponsored by UTHealth Houston. Primary endpoints: Inhibitor development, Anti-factor VIII antibody subclasses and 5 more. Started May 2013; status: active, not recruiting.
02
Drugs
Factor VIII
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NL-OMON39820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39820.